Status:
COMPLETED
Platelet Indices and Recurrent Pregnancy Loss
Lead Sponsor:
Menoufia University
Conditions:
Abortion, Recurrent
Eligibility:
FEMALE
18-40 years
Brief Summary
The aim of this study was to evaluate relationship between platelet indices, red blood cell indices and recurrent pregnancy loss.
Detailed Description
Recurrent pregnancy loss is defined as three or more consecutive pregnancy losses at or less than 20 weeks of gestation or with a fetal weight less than 500 gram. The American society for reproductive...
Eligibility Criteria
Inclusion
- patients with Recurrent miscarriage is defined as three or more consecutive pregnancy losses at or less than 20 weeks of gestation or with a fetal weight less than 500 grams
Exclusion
- A woman who had experienced recurrent pregnancy loss due to uterine anomalies, diabetes mellitus and thyroid disease.
- Hypertensive women.
- Patients with coagulation defects.
- History of deep vein thrombosis or pulmonary thromboembolism.
- Use of medications affecting platelet functions such as aspirin, nonsteroidal anti-inflammatory drugs, oral contraceptives, hormonal treatments, anti-platelet, and anticoagulant drugs.
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05190796
Start Date
September 1 2020
End Date
November 1 2021
Last Update
January 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Menoufia University hospital
Shibīn al Kawm, Menoufia, Egypt, 11111